Coronavirus from Earth’s Perspective

James West
|

There’s no denying that Coronavirus has accomplished in 3 months what a lifetime of Extinction Rebellion and Greenpeace protests have not: global emissions reductions are substantially down since the virus has curbed air and sea travel by 90 percent.

And while we like to look for an animal or a nation to blame for its emergence, COVID-19 is nothing more or less than the Earth’s own immune system waking up and going to war against the human virus that is undermining all of its natural systems. The ratio of human beings to the rest of Earth’s flora and fauna is woefully disproportionate, when one considers the average ratio of non-human populations in nature relative to one another.

In many respects, that is a good thing.

If mankind can’t modulate his consumption and exhaust, then Earth is certainly not one to shirk the task.

The ability of human beings to see the Coronavirus outbreak in such terms is limited to a very tiny minuscule portion of the population. In fact, it is precisely because this tiny yet visionary percentage of the population are unable to convince the vast majority that these transgressions against ecological systems are compounding the threat to the continued existence to humanity as a whole, that is the reason we are in the predicament we are in.

And when you consider the multi-faceted relentless assault on Earth’s ecological systems that is the byproduct of our global economy in full swing and growing by several percentage points each year, the chances of this Coronavirus pandemic being a one-off are very slim.

It is more likely that this outbreak is just another (after SARS, MERS, AIDS, Hantavirus, Juninvirus, Ebola, TB, Bubonic Plague, etc) in a long line of manifestations of the planet’s own autoimmune system attempts to bring the disproportionate excess of human beings and their destructive activities into what would be considered (by the planet) to be a more “natural balance”.

Note that we already know what is meant by “natural balance” without needing anyone to explain it to us.

The natural balance that is the cornerstone of a healthy ecological system is one of the most fundamentally understood concepts by any human being.

The fact that we continue overproduce and own objects in abundance for which we have little emergent use is in fact, our death sentence as a species.

So get ready for a long line of “novel” outbreaks yet to come. And while we bob and weave as a society to try and escape the worst case scenario of such outbreaks, we will continue to innovate and defend ourselves against these outbreaks with a frantic technological output that will rival war-time productivity and dwarf it.

As we speak, there are hundreds of companies and medical professionals fighting to stop the spread of the virus. Millions of dollars are being poured into research and clinical trials, hoping existing medicines can be transformed from treating the outbreaks mentioned above (eg. HIV, Malaria, etc.) and benefit the current pandemic.

There are a variety of avenues companies can look towards when treating COVID-19: drugs targeting the virus is the obvious first step but aiding symptoms and boosting immune systems are currently being explored for production.

Tomorrow at 2pm ET, I’m hosting an informational session where I will be outlining a handful of companies who are doing exactly that. Companies that are close to finding the cure. In addition to supporting the people most at need during these troubling times, there is a massive investment upside to be had.

Click here to grab your seat to my announcement.

James West

James West

Editor and Publisher

James West founded Midas Letter in 2008 and has since been covering the best of Canadian and US small cap companies. He covers global economics, monetary policy, geopolitical evolution, political corruption, commodities, cannabis and cryptocurrencies. As an active market participant, James is not a journalist and is invariably discussing markets...
More Info...

[email protected] | |

Midas Letter is provided as a source of information only, and is in no way to be construed as investment advice. James West, the author and publisher of the Midas Letter, is not authorized to provide investor advice, and provides this information only to readers who are interested in knowing what he is investing in and how he reaches such decisions.

Investing in emerging public companies involves a high degree of risk and investors in such companies could lose all their money. Always consult a duly accredited investment professional in your jurisdiction prior to making any investment decision.

Midas Letter occasionally accepts fees for advertising and sponsorship from public companies featured on this site. James West and/or Midas Letter may also receive compensation from companies affiliated with companies featured on this site. James West and/or Midas Letter also invests in companies on this site and so readers should view all information on this site as biased.